Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 20, 2006
ODYSSEY HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
| Texas | 000-33267 | 43-1723043 | ||
| (State or other | (Commission File Number) | (I.R.S. Employer | ||
| jurisdiction of incorporation) | Identification Number) |
| 717 North Harwood Street, Suite 1500 | ||
| Dallas, Texas | 75201 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:(214) 922-9711
Not Applicable
(Former name or former address, if changed since last report)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Table of Contents
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective November 20, 2006, Martin S. Rash resigned from the Board of Directors of Odyssey HealthCare, Inc. (the “Board”). Mr. Rash was a member of the Audit Committee and the Compensation Committee of the Board. Mr. Rash’s resignation from the Board leaves a Class III director vacancy on the Board.
Item 8.01 Other Events.
On November 21, 2006, Odyssey HealthCare, Inc. (the “Company”) issued a press release announcing that its Board has approved a new stock repurchase program. This new program authorizes the Company to repurchase up to $10 million of its common stock through the open market over the next twelve months. A copy of the press release is attached hereto as Exhibit 99.1 to this Form 8-K.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. |
| 99.1 | Press release dated November 21, 2006. |
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ODYSSEY HEALTHCARE, INC. | ||||
| Date: November 21, 2006 | By: | /s/ R. Dirk Allison | ||
| R. Dirk Allison Senior Vice President and Chief Financial Officer | ||||